Lifecore Biomedical, Inc. De (LFCR) Market Capitalization (2010 - 2025)

Lifecore Biomedical has reported Market Capitalization for 16 years, with the latest figure at $248.8 million in Q2 2025.

• On a quarterly basis, Market Capitalization rose 44.86% year-over-year to $248.8 million in Q2 2025; TTM through May 2025 was $248.8 million, a 44.86% increase from a year earlier, with the FY2025 full-year figure at $248.8 million, up 44.86% from the prior year.
• Market Capitalization was $248.8 million for Q2 2025 at Lifecore Biomedical, up from $207.7 million in the prior quarter.
• The five-year high for Market Capitalization was $351.1 million in Q2 2021, with the low at $171.8 million in Q2 2024.
• Average Market Capitalization over 5 years is $259.6 million, with a median of $254.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization slumped 47.87% in 2023, then jumped 44.86% in 2025.
• Over 5 years, Market Capitalization stood at $255.6 million in 2021, then dropped by 0.79% to $253.6 million in 2022, then fell by 9.8% to $228.7 million in 2023, then rose by 18.18% to $270.3 million in 2024, then fell by 7.96% to $248.8 million in 2025.
• The last three Market Capitalization figures came in at $248.8 million (Q2 2025), $207.7 million (Q1 2025), and $270.3 million (Q4 2024), per Business Quant data.